Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION
 
Authors :  A. C. W. Pike, A. M. Brzozowski, S. M. Roberts, O. H. Olsen, E. Persson
Date :  12 Apr 99  (Deposition) - 01 Aug 99  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.80
Chains :  Asym./Biol. Unit :  H,L
Keywords :  Blood Coagulation, Serine Protease, Hydrolase-Hydrolase Inhibitor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  A. C. Pike, A. M. Brzozowski, S. M. Roberts, O. H. Olsen, E. Persson
Structure Of Human Factor Viia And Its Implications For The Triggering Of Blood Coagulation.
Proc. Natl. Acad. Sci. Usa V. 96 8925 1999
PubMed-ID: 10430872  |  Reference-DOI: 10.1073/PNAS.96.16.8925

(-) Compounds

Molecule 1 - COAGULATION FACTOR VIIA LIGHT CHAIN
    ChainsL
    EC Number3.4.21.21
    EngineeredYES
    Expression SystemMESOCRICETUS AURATUS
    Expression System Cellular LocationSECRETED
    Expression System Cell LineBHK570
    Expression System CollectionATCC CRL 1632
    Expression System CommonGOLDEN HAMSTER
    Expression System GeneFACTOR VII
    Expression System OrganelleNUCLEUS
    Expression System PlasmidZEM219B
    Expression System Taxid10036
    Expression System Vector TypePLASMID
    FragmentUNP RESIDUES 109-212
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymFVIIA
    TissueBLOOD
 
Molecule 2 - COAGULATION FACTOR VIIA HEAVY CHAIN
    ChainsH
    EC Number3.4.21.21
    EngineeredYES
    Expression SystemMESOCRICETUS AURATUS
    Expression System Cellular LocationSECRETED
    Expression System Cell LineBHK570
    Expression System CollectionATCC CRL 1632
    Expression System CommonGOLDEN HAMSTER
    Expression System GeneFACTOR VII
    Expression System OrganelleNUCLEUS
    Expression System PlasmidZEM219B
    Expression System Taxid10036
    Expression System Vector TypePLASMID
    FragmentUNP RESIDUES 213-466
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymFVIIA
    TissueBLOOD

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit HL

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (6, 7)

Asymmetric/Biological Unit (6, 7)
No.NameCountTypeFull Name
10Z61Ligand/IonD-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-PHENYLALANINAMIDE
2CA1Ligand/IonCALCIUM ION
3FUC1Ligand/IonALPHA-L-FUCOSE
4FUL1Ligand/IonBETA-L-FUCOSE
5GLC1Ligand/IonALPHA-D-GLUCOSE
6NAG2Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (7, 7)

Asymmetric Unit (7, 7)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREHOH H:39 , HIS H:193 , THR H:238 , THR H:239 , PRO H:321 , ASP H:338 , SER H:339 , CYS H:340 , LYS H:341 , GLY H:342 , ASP H:343 , SER H:344 , SER H:363 , TRP H:364 , GLY H:365 , GLN H:366 , GLY H:367 , CYS H:368BINDING SITE FOR RESIDUE 0Z6 H 1
2AC2SOFTWAREASP H:319 , SER H:320 , ASN H:322 , NAG H:461 , FUL H:465 , HOH H:554BINDING SITE FOR RESIDUE NAG H 460
3AC3SOFTWARENAG H:460 , HOH H:560BINDING SITE FOR RESIDUE NAG H 461
4AC4SOFTWAREALA H:274 , PHE H:275 , ARG H:277 , NAG H:460 , HOH H:506BINDING SITE FOR RESIDUE FUL H 465
5AC5SOFTWAREGLN L:49 , SER L:52BINDING SITE FOR RESIDUE GLC L 153
6AC6SOFTWARESER L:60BINDING SITE FOR RESIDUE FUC L 160
7AC7SOFTWAREGLU H:210 , ASP H:212 , GLU H:215 , GLU H:220 , HOH H:547 , HOH H:561BINDING SITE FOR RESIDUE CA H 500

(-) SS Bonds  (11, 11)

Asymmetric/Biological Unit
No.Residues
1H:159 -H:164
2H:178 -H:194
3H:310 -H:329
4H:340 -H:368
5L:50 -L:61
6L:55 -L:70
7L:72 -L:81
8L:91 -L:102
9L:98 -L:112
10L:114 -L:127
11L:135 -H:262

(-) Cis Peptide Bonds  (1, 1)

Asymmetric/Biological Unit
No.Residues
1Phe H:405 -Pro H:406

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (102, 102)

Asymmetric/Biological Unit (102, 102)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
001UniProtVAR_065376N117DFA7_HUMANDisease (FA7D)121964932LN57D
002UniProtVAR_015136S120PFA7_HUMANDisease (FA7D)  ---LS60P
003UniProtVAR_014407C121FFA7_HUMANDisease (FA7D)  ---LC61F
004UniProtVAR_014408L125PFA7_HUMANDisease (FA7D)  ---LL65P
005UniProtVAR_014409Y128CFA7_HUMANDisease (FA7D)  ---LY68C
006UniProtVAR_065377G138DFA7_HUMANDisease (FA7D)  ---LG78D
007UniProtVAR_006497R139KFA7_HUMANDisease (FA7D)  ---LR79K
008UniProtVAR_006498R139QFA7_HUMANDisease (FA7D)150525536LR79Q
009UniProtVAR_006499R139WFA7_HUMANDisease (FA7D)776796178LR79W
010UniProtVAR_014410C151SFA7_HUMANDisease (FA7D)  ---LC91S
011UniProtVAR_015137E154KFA7_HUMANDisease (FA7D)146795869LE94K
012UniProtVAR_065378G156SFA7_HUMANDisease (FA7D)563972504LG96S
013UniProtVAR_006501G157CFA7_HUMANDisease (FA7D)  ---LG97C
014UniProtVAR_006500G157SFA7_HUMANDisease (FA7D)763458490LG97S
015UniProtVAR_014411G157VFA7_HUMANDisease (FA7D)771335282LG97V
016UniProtVAR_006502Q160RFA7_HUMANDisease (FA7D)200016360LQ100R
017UniProtVAR_065379S171FFA7_HUMANDisease (FA7D)143855920LS111F
018UniProtVAR_065380G177RFA7_HUMANDisease (FA7D)  ---LG117R
019UniProtVAR_065381L181PFA7_HUMANDisease (FA7D)  ---LL121P
020UniProtVAR_065382D183NFA7_HUMANDisease (FA7D)  ---LD123N
021UniProtVAR_065383S186FFA7_HUMANDisease (FA7D)764971156LS126F
022UniProtVAR_065384P189SFA7_HUMANDisease (FA7D)  ---LP129S
023UniProtVAR_065385P194LFA7_HUMANDisease (FA7D)  ---LP134L
024UniProtVAR_006503P194TFA7_HUMANDisease (FA7D)  ---LP134T
025UniProtVAR_014412C195RFA7_HUMANDisease (FA7D)372577568LC135R
026UniProtVAR_006504K197EFA7_HUMANDisease (FA7D)  ---LK137E
027UniProtVAR_065386I198TFA7_HUMANDisease (FA7D)762621913LI138T
028UniProtVAR_015138G216DFA7_HUMANDisease (FA7D)  ---HG156D
029UniProtVAR_006506C238YFA7_HUMANDisease (FA7D)121964928HC178Y
030UniProtVAR_065387G240RFA7_HUMANDisease (FA7D)  ---HG180R
031UniProtVAR_014413T241NFA7_HUMANDisease (FA7D)  ---HT181N
032UniProtVAR_065388S250FFA7_HUMANDisease (FA7D)  ---HS190F
033UniProtVAR_065389A251PFA7_HUMANDisease (FA7D)  ---HA191P
034UniProtVAR_065390A251TFA7_HUMANDisease (FA7D)  ---HA191T
035UniProtVAR_065391C254RFA7_HUMANDisease (FA7D)  ---HC194R
036UniProtVAR_015139C254YFA7_HUMANDisease (FA7D)  ---HC194Y
037UniProtVAR_065392L264PFA7_HUMANDisease (FA7D)753266903HL204P
038UniProtVAR_015140A266TFA7_HUMANDisease (FA7D)764807079HA206T
039UniProtVAR_065393D272NFA7_HUMANDisease (FA7D)751028917HD212N
040UniProtVAR_065394D277NFA7_HUMANDisease (FA7D)550074221HD217N
041UniProtVAR_006507R283WFA7_HUMANDisease (FA7D)779589651HR223W
042UniProtVAR_013936V295DFA7_HUMANPolymorphism6045HV235D
043UniProtVAR_065395T298IFA7_HUMANDisease (FA7D)  ---HT238I
044UniProtVAR_065396H301QFA7_HUMANDisease (FA7D)  ---HH241Q
045UniProtVAR_014414D302HFA7_HUMANDisease (FA7D)  ---HD242H
046UniProtVAR_014415D302NFA7_HUMANDisease (FA7D)770328850HD242N
047UniProtVAR_014416A304TFA7_HUMANDisease (FA7D)773627551HA244T
048UniProtVAR_006508A304VFA7_HUMANDisease (FA7D)121964931HA244V
049UniProtVAR_014417R307CFA7_HUMANDisease (FA7D)147680958HR247C
050UniProtVAR_006509R307HFA7_HUMANDisease (FA7D)121964929HR247H
051UniProtVAR_015141V312MFA7_HUMANDisease (FA7D)201991361HV252M
052UniProtVAR_065397L314VFA7_HUMANDisease (FA7D)  ---HL254V
053UniProtVAR_065398L321FFA7_HUMANDisease (FA7D)778138366HL261F
054UniProtVAR_065399L323RFA7_HUMANDisease (FA7D)  ---HL263R
055UniProtVAR_006510E325KFA7_HUMANDisease (FA7D)749760143HE265K
056UniProtVAR_065400R326QFA7_HUMANDisease (FA7D)146698837HR266Q
057UniProtVAR_014418T332MFA7_HUMANDisease (FA7D)200212201HT272M
058UniProtVAR_065401R337CFA7_HUMANDisease (FA7D)139372641HR277C
059UniProtVAR_015142V341FFA7_HUMANDisease (FA7D)  ---HV281F
060UniProtVAR_065402G343SFA7_HUMANDisease (FA7D)  ---HG283S
061UniProtVAR_076570W344GFA7_HUMANDisease (FA7D)  ---HW284G
062UniProtVAR_065403W344RFA7_HUMANDisease (FA7D)  ---HW284R
063UniProtVAR_065404G345SFA7_HUMANDisease (FA7D)  ---HG285S
064UniProtVAR_065405R350CFA7_HUMANDisease (FA7D)747876824HR290C
065UniProtVAR_013122A352TFA7_HUMANPolymorphism3093267HA292T
066UniProtVAR_006511A354VFA7_HUMANDisease (FA7D)36209567HA294V
067UniProtVAR_006512M358IFA7_HUMANDisease (FA7D)149283257HM298I
068UniProtVAR_006513M358VFA7_HUMANDisease (FA7D)  ---HM298V
069UniProtVAR_065406L360PFA7_HUMANDisease (FA7D)  ---HL300P
070UniProtVAR_065407P363HFA7_HUMANDisease (FA7D)  ---HP303H
071UniProtVAR_015143P363RFA7_HUMANDisease (FA7D)  ---HP303R
072UniProtVAR_006514R364QFA7_HUMANDisease (FA7D)121964926HR304Q
073UniProtVAR_065408R364WFA7_HUMANDisease (FA7D)750980786HR304W
074UniProtVAR_018671T367SFA7_HUMANPolymorphism747673406HT307S
075UniProtVAR_006515C370FFA7_HUMANDisease (FA7D)121964927HC310F
076UniProtVAR_065410T384MFA7_HUMANDisease (FA7D)531225271HT324M
077UniProtVAR_065411M387TFA7_HUMANDisease (FA7D)  ---HM327T
078UniProtVAR_065412M387VFA7_HUMANDisease (FA7D)  ---HM327V
079UniProtVAR_065413F388SFA7_HUMANDisease (FA7D)121964938HF328S
080UniProtVAR_014392C389GFA7_HUMANDisease (FA7D)121964934HC329G
081UniProtVAR_065414G391CFA7_HUMANDisease (FA7D)  ---HG331C
082UniProtVAR_014419G391SFA7_HUMANDisease (FA7D)190485816HG331S
083UniProtVAR_065415D398EFA7_HUMANDisease (FA7D)  ---HD338E
084UniProtVAR_065416K401EFA7_HUMANDisease (FA7D)748979195HK341E
085UniProtVAR_006517G402EFA7_HUMANDisease (FA7D)  ---HG342E
086UniProtVAR_006516G402RFA7_HUMANDisease (FA7D)  ---HG342R
087UniProtVAR_015144D403HFA7_HUMANDisease (FA7D)  ---HD343H
088UniProtVAR_065417S404NFA7_HUMANDisease (FA7D)  ---HS344N
089UniProtVAR_065418H408QFA7_HUMANDisease (FA7D)121964936HH348Q
090UniProtVAR_065419H408RFA7_HUMANDisease (FA7D)  ---HH348R
091UniProtVAR_065420R413GFA7_HUMANDisease (FA7D)  ---HR353G
092UniProtVAR_006518R413QFA7_HUMANPolymorphism6046HR353Q
093UniProtVAR_065421G414CFA7_HUMANDisease (FA7D)121964937HG354C
094UniProtVAR_006519T419MFA7_HUMANDisease (FA7D)121964930HT359M
095UniProtVAR_065422V422FFA7_HUMANDisease (FA7D)  ---HV362F
096UniProtVAR_065423G425AFA7_HUMANDisease (FA7D)  ---HG365A
097UniProtVAR_065424G425CFA7_HUMANDisease (FA7D)  ---HG365C
098UniProtVAR_065425A429TFA7_HUMANDisease (FA7D)755377592HA369T
099UniProtVAR_065426G432DFA7_HUMANDisease (FA7D)  ---HG372D
100UniProtVAR_014420G435EFA7_HUMANDisease (FA7D)756956471HG375E
101UniProtVAR_065427Y437FFA7_HUMANDisease (FA7D)758213652HY377F
102UniProtVAR_013123E445KFA7_HUMANPolymorphism3093248HE385K

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (6, 6)

Asymmetric/Biological Unit (6, 6)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1ASX_HYDROXYLPS00010 Aspartic acid and asparagine hydroxylation site.FA7_HUMAN121-132  1L:61-72
2EGF_1PS00022 EGF-like domain signature 1.FA7_HUMAN130-141  1L:70-81
3EGF_2PS01186 EGF-like domain signature 2.FA7_HUMAN172-187  1L:112-127
4TRYPSIN_DOMPS50240 Serine proteases, trypsin domain profile.FA7_HUMAN213-452  1H:153-392
5TRYPSIN_HISPS00134 Serine proteases, trypsin family, histidine active site.FA7_HUMAN249-254  1H:189-194
6TRYPSIN_SERPS00135 Serine proteases, trypsin family, serine active site.FA7_HUMAN398-409  1H:338-349

(-) Exons   (5, 6)

Asymmetric/Biological Unit (5, 6)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1bENST000003755811bENSE00001891092chr13:113760121-11376021999FA7_HUMAN1-22220--
1.2ENST000003755812ENSE00000862519chr13:113761159-11376122466FA7_HUMAN22-44230--
1.3cENST000003755813cENSE00001135032chr13:113765004-113765164161FA7_HUMAN44-97540--
1.4aENST000003755814aENSE00000862522chr13:113768066-11376809025FA7_HUMAN98-10690--
1.4cENST000003755814cENSE00001135014chr13:113768161-113768274114FA7_HUMAN106-144391-
L:49-84
-
36
1.7ENST000003755817ENSE00001786842chr13:113769974-113770114141FA7_HUMAN144-191481-
L:84-131
-
48
1.8cENST000003755818cENSE00001134999chr13:113771080-113771189110FA7_HUMAN191-227372H:153-167
L:131-144
15
14
1.9ENST000003755819ENSE00000687189chr13:113771787-113771910124FA7_HUMAN228-269421H:168-209
-
42
-
1.10bENST0000037558110bENSE00001467515chr13:113772727-1137749952269FA7_HUMAN269-4661981H:209-406 (gaps)
-
198
-

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain H from PDB  Type:PROTEIN  Length:252
 aligned with FA7_HUMAN | P08709 from UniProtKB/Swiss-Prot  Length:466

    Alignment length:254
                                   222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462    
            FA7_HUMAN   213 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP 466
               SCOP domains d1qfkh_ H: Coagulation factor VIIa                                                                                                                                                                                                                             SCOP domains
               CATH domains 1qfkH01     1qfkH02 H:165-260,H:382-395 Trypsin-like serine proteases                                       1qfkH01 H:153-164,H:261-381 Trypsin-like serine protea  ses                                                              1qfkH02       ----------- CATH domains
               Pfam domains Trypsin-1qfkH01 H:153-387                                                                                                                                                                                                                  ------------------- Pfam domains
         Sec.struct. author ..............eeeeee..eeeeeee.....eeee.hhhh........eeeee............eeeeeeeeeee............eeeee.................hhhhhh.hhh..eeeeee..............eeeeee...hhh.....--..........eeee................eeeeee..eeeeeeeeeee.........eeeeehhhhhhhhhhhh........eeee... Sec.struct. author
             SAPs(SNPs) (1) ---D---------------------Y-RN--------FP--R---------P-T-----N----N-----W-----------D--I--QH-T--C----M-V------F-R-KQ-----M----C---F-SGS----C-T-V---I-P--HQ--S--F-------------M--TSG-C------E--EEHN---Q----GC----M--F--A---T--D--E-F-------K--------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------T--Y-----------------------------------------------N-V--H------------------------------------R-------------V----RW----------------------V---S----------R-----R----Q-----------C----------------------------------------- SAPs(SNPs) (2)
                PROSITE (1) TRYPSIN_DOM  PDB: H:153-392 UniProt: 213-452                                                                                                                                                                                                    -------------- PROSITE (1)
                PROSITE (2) ------------------------------------TRYPSI-----------------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER --------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.8c      -----------------------------------------Exon 1.10b  PDB: H:209-406 (gaps) UniProt: 269-466                                                                                                                                                     Transcript 1 (1)
           Transcript 1 (2) ---------------Exon 1.9  PDB: H:168-209 UniProt: 228-269 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 1qfk H 153 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQS--VGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP 406
                                   162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312 |  |  322       332       342       352       362       372       382       392       402    
                                                                                                                                                                                           314  |                                                                                         
                                                                                                                                                                                              317                                                                                         

Chain L from PDB  Type:PROTEIN  Length:96
 aligned with FA7_HUMAN | P08709 from UniProtKB/Swiss-Prot  Length:466

    Alignment length:96
                                   118       128       138       148       158       168       178       188       198      
            FA7_HUMAN   109 QCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR 204
               SCOP domains d1qfkl1 L:49-86                       d1qfkl2 L:87-144 Coagulation factor VIIa                   SCOP domains
               CATH domains 1qfkL01 L:49-85 Laminin              1qfkL02 L:86-144 Laminin                                    CATH domains
               Pfam domains -EGF-1qfkL01 L:50-80            ---------------------------------------------------------------- Pfam domains
         Sec.struct. author .hhh.......eeeee..eeeee.............hhh.......hhh....................eee......eee.........hhhh.. Sec.struct. author
             SAPs(SNPs) (1) --------D--PF---P--C---------DK-----------S--K-SC--R----------F-----R---P-N--F--S----LR-ET------ SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------Q-----------------S------------------------------------T---------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------W-----------------V----------------------------------------------- SAPs(SNPs) (3)
                PROSITE (1) ------------ASX_HYDROXYL---------------------------------------EGF_2           ----------------- PROSITE (1)
                PROSITE (2) ---------------------EGF_1       --------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.4c  PDB: L:49-84 [INCOMPLETE]----------------------------------------------Exon 1.8c      Transcript 1 (1)
           Transcript 1 (2) -----------------------------------Exon 1.7  PDB: L:84-131 UniProt: 144-191        ------------- Transcript 1 (2)
                 1qfk L  49 QCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR 144
                                    58        68        78        88        98       108       118       128       138      

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 3)

Asymmetric/Biological Unit

(-) CATH Domains  (2, 4)

Asymmetric/Biological Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (2, 2)

Asymmetric/Biological Unit
(-)
Clan: EGF (60)

(-) Gene Ontology  (35, 35)

Asymmetric/Biological Unit(hide GO term definitions)
Chain H,L   (FA7_HUMAN | P08709)
molecular function
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0004175    endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0004252    serine-type endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
    GO:0008236    serine-type peptidase activity    Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
    GO:0006888    ER to Golgi vesicle-mediated transport    The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
    GO:0031100    animal organ regeneration    The regrowth of a lost or destroyed animal organ.
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0007598    blood coagulation, extrinsic pathway    A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
    GO:0007623    circadian rhythm    Any biological process in an organism that recurs with a regularity of approximately 24 hours.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:0017187    peptidyl-glutamic acid carboxylation    The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
    GO:0030194    positive regulation of blood coagulation    Any process that activates or increases the frequency, rate or extent of blood coagulation.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0002690    positive regulation of leukocyte chemotaxis    Any process that activates or increases the frequency, rate, or extent of leukocyte chemotaxis.
    GO:0010641    positive regulation of platelet-derived growth factor receptor signaling pathway    Any process that increases the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
    GO:0050927    positive regulation of positive chemotaxis    Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
    GO:0051897    positive regulation of protein kinase B signaling    Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0043627    response to estrogen    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
    GO:0060416    response to growth hormone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
    GO:0009725    response to hormone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
    GO:0031667    response to nutrient levels    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
    GO:0014070    response to organic cyclic compound    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
    GO:0032571    response to vitamin K    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin K stimulus.
    GO:0006465    signal peptide processing    The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
cellular component
    GO:0005796    Golgi lumen    The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0031982    vesicle    Any small, fluid-filled, spherical organelle enclosed by membrane.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    0Z6  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    CA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FUC  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FUL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    GLC  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Phe H:405 - Pro H:406   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1qfk
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FA7_HUMAN | P08709
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.4.21.21
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  227500
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FA7_HUMAN | P08709
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FA7_HUMAN | P087091bf9 1cvw 1dan 1dva 1f7e 1f7m 1fak 1ff7 1ffm 1j9c 1jbu 1kli 1klj 1nl8 1o5d 1w0y 1w2k 1w7x 1w8b 1wqv 1wss 1wtg 1wun 1wv7 1ygc 1z6j 2a2q 2aei 2aer 2b7d 2b8o 2bz6 2c4f 2ec9 2f9b 2fir 2flb 2flr 2puq 2zp0 2zwl 2zzu 3ela 3th2 3th3 3th4 4ibl 4ish 4isi 4jyu 4jyv 4jzd 4jze 4jzf 4na9 4ng9 4nga 4x8s 4x8t 4x8u 4x8v 4ylq 4yt6 4yt7 4z6a 4zma 4zxx 4zxy 5i46 5l2y 5l2z 5l30 5pa8 5pa9 5paa 5pab 5pac 5pae 5paf 5pag 5pai 5paj 5pak 5pam 5pan 5pao 5paq 5par 5pas 5pat 5pau 5pav 5paw 5pax 5pay 5pb0 5pb1 5pb2 5pb3 5pb4 5pb5 5pb6 5tqe 5tqf 5tqg 5u6j

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 1QFK)